AzTrials
AzTrials

FrailtyNCT05452395

Post-acute Care for Patients With Frailty

A study testing Post-acute care in people with Frailty and Retrospective Study, run by Taipei City Hospital at 1 site in Taiwan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Acute illness could be enormous stress for frail people. Combining comprehensive geriatric assessment and multifactorial intervention has positive effects on frail community older adults. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Frailty, Retrospective Study
What is being tested?
Post-acute care
Could I receive a placebo?
No, everyone receives an active treatment
How many people
254 participants
Where
1 siteTaiwan
Study dates
19 Jun 2020to 31 Dec 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Mild to severe frailty identified by the Clinical Frailty Scale
  • Age ≥ 75 years
  • Diagnosis with Parkinson's disease, dementia, chronic obstructive pulmonary disease, or chronic kidney disease stage three or worse
  • Acute hospital stays between 3 to 30 days with deconditioning
  • Stable medical condition with no need of intensive care, laboratory examination, or oxygen dependence

Who cannot join

  • Refused to participate in the program
  • Candidate for other post-acute care programs (i.e. stroke, traumatic neurological injury, or fracture)
  • Unable to cooperate with the program due to mental or cognitive impairment
  • Long-term ventilator-dependence
  • Long-term bed-ridden status (> 6 months)
  • Diagnosed as end of life and in need of palliative care
Show all 9Show fewer
  • Diagnosed as major illness (i.e. end-stage renal disease) and in need of frequent inpatient treatment ( > 3 times over recent 6 months)
  • Institutional residents
  • Home medical care participants

Trial locations and contacts

1 site in 1 country.

Taiwan1 site
  • Taipei City Hospital

    Taipei

Other trials in Taiwan

About this study

Official title: Integrated Post-Acute Care Program for Frail Elderly

Acute illness could be enormous stress for frail people. Combining comprehensive geriatric assessment and multifactorial intervention has positive effects on frail community older adults. However, few studies investigated the effects of post-acute care (PAC) in frail older patients who just recovered from acute hospitalization. This study aimed to evaluate the effects of PAC on frail older adults in Taiwan.

Read the detailed description

Frail patients aged >= 75 were recruited and divided into PAC or control groups. The PAC group received comprehensive geriatric assessment (CGA) and multifactorial intervention for two to four weeks. The control group received CGA only. The primary outcomes were 90-day emergency room visits, readmissions, and mortality after PAC.

Being tested
Post-acute care
Medical subject headings
Frailty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Post-acute careOther

    A personalized care program, focusing on managing geriatric syndromes and improving functional performances.

    Strength training, activities of daily living (ADL) and instrumental activities of daily living (IADL) practice, basic mobility training, reconditioning exercise, and home environment assessment and modification.

Study groups in NCT05452395
Study groupRoleWhat they receive
Post-acute careExperimentalcomprehensive geriatric assessment, and either home-based or hospital-based post-acute care
Receives: Other: Post-acute care
control groupNo interventioncomprehensive geriatric assessment only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. 90-day emergency room visits

    Emergency room visits after post-acute care

    Measured: 90 days after post-acute care

  2. 90-day readmissions

    Readmissions visits after post-acute care

    Measured: 90 days after post-acute care

  3. 90-day mortality

    Mortality after post-acute care

    Measured: 90 days after post-acute care

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Jul 2022
  2. Study start19 Jun 2020
  3. Primary completion31 Dec 2020
  4. Study completion31 Dec 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
254 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05452395
Sponsor's protocol ID
TPECH-frailty
Status last verified
Jul 2022
First submitted
6 Jul 2022
Last updated
11 Jul 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Lee MC, Wu TY, Huang SJ, Chen YM, Hsiao SH, Tsai CY. Post-acute care for frail older people decreases 90-day emergency room visits, readmissions and mortality: An interventional study. PLoS One. 2023 Jan 6;18(1):e0279654. doi: 10.1371/journal.pone.0279654. eCollection 2023.

    PubMed 36607971

Questions about this trial

What is this clinical trial studying?

A study testing Post-acute care in people with Frailty and Retrospective Study, run by Taipei City Hospital at 1 site in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jul 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

90-day emergency room visits (time frame: 90 days after post-acute care). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05452395, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in